The main sticking-point had been the refusalof America's Food and Drug Administration to forgo its right to approve all products sold in the United States.
Equally impressive was the refusalof Frances Kelsey, who was responsible for vetting thalidomide at America's Food and Drug Administration, to bend to corporate pressure and approve the drug for general use.